Sharing Alzheimer's Research Data with the World

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) unites researchers with study data as they work to define the progression of Alzheimer’s disease. ADNI researchers collect, validate and utilize data such as MRI and PET images, genetics, cognitive tests, CSF and blood biomarkers as predictors for the disease. Data from the North American ADNI’s study participants, including Alzheimer’s disease patients, mild cognitive impairment subjects and elderly controls, are available from this site.

Join ADNI as a research participant.


Returning Users


Sanger Sequencing Dataset Available

New results from Sanger Sequencing of SNPs are now available from the Genetic Data...

Updated MRI MCH Results Available – New ADNIGO/2 records added

New ADNI2, ADNIGo records were added to the MRI micro-hemorrhage assessment results dataset. The dataset...
RSS Feed More News >